Concordance was good , with a kappa value of 0.63 in analyzable patients , and 46.7 % diagnosis with CapsoCam vs. 48.3 % with PillCam SB2.CapsoCam and PillCam SB2 procedures identified 81.8 % ( 27/33 ) and 84.8 % ( 28/33 ) of positive patients , respectively ( P = 0.791 ) .